These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 20573443)
41. Do patients with symptoms and signs of lower urinary tract dysfunction need a urodynamic diagnosis? ICI-RS 2013. Rosier PF; Giarenis I; Valentini FA; Wein A; Cardozo L Neurourol Urodyn; 2014 Jun; 33(5):581-6. PubMed ID: 24844430 [TBL] [Abstract][Full Text] [Related]
42. Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration. Wein AJ; Khullar V; Wang JT; Guan Z BJU Int; 2007 Feb; 99(2):360-3. PubMed ID: 17155987 [TBL] [Abstract][Full Text] [Related]
43. Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. Cardozo L; Staskin D; Currie B; Wiklund I; Globe D; Signori M; Dmochowski R; MacDiarmid S; Nitti VW; Noblett K Int Urogynecol J; 2014 Dec; 25(12):1655-63. PubMed ID: 24859795 [TBL] [Abstract][Full Text] [Related]
44. Pelvic floor electrostimulation in women with urinary incontinence and/or overactive bladder syndrome: a systematic review. Jerez-Roig J; Souza DL; Espelt A; Costa-Marín M; Belda-Molina AM Actas Urol Esp; 2013; 37(7):429-44. PubMed ID: 23246103 [TBL] [Abstract][Full Text] [Related]
45. Predictive Factors of De Novo Overactive Bladder After Artificial Urinary Sphincter Implantation in Men With Postprostatectomy Incontinence. Ko KJ; Lee CU; Kim TH; Suh YS; Lee KS Urology; 2018 Mar; 113():215-219. PubMed ID: 29030076 [TBL] [Abstract][Full Text] [Related]
46. The prevalence of overactive bladder syndrome and urinary incontinence in a Turkish women population; associated risk factors and effect on Quality of life. Sarici H; Ozgur BC; Telli O; Doluoglu OG; Eroglu M; Bozkurt S Urologia; 2016 May; 83(2):93-8. PubMed ID: 24803353 [TBL] [Abstract][Full Text] [Related]
47. Impact of daily number of urgency urinary incontinence episodes on overactive bladder patient reported outcomes. Angulo JC; Brenes FJ; Lizarraga I; Rejas J; Trillo S; Ochayta D; Arumi D Actas Urol Esp; 2016 Apr; 40(3):173-82. PubMed ID: 26811022 [TBL] [Abstract][Full Text] [Related]
48. Urodynamics less likely to change diagnosis and management in uncomplicated overactive bladder. English K; Maiman R; Laudano M; Abraham N Can J Urol; 2020 Jun; 27(3):10244-10249. PubMed ID: 32544048 [TBL] [Abstract][Full Text] [Related]
49. Prevalence and impact of lower urinary tract symptoms: Results of the epic survey in Egypt. Mourad S; Shokeir A; Ayoub N; Ibrahim M; Reynolds N; Donde S; Hassan T Neurourol Urodyn; 2019 Feb; 38(2):637-643. PubMed ID: 30575129 [TBL] [Abstract][Full Text] [Related]
50. Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review. Bartoli S; Aguzzi G; Tarricone R Urology; 2010 Mar; 75(3):491-500. PubMed ID: 19962738 [TBL] [Abstract][Full Text] [Related]
51. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial. Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358 [TBL] [Abstract][Full Text] [Related]
52. Clinical characteristics, beliefs, and coping strategies among older patients with overactive bladder. Blasco P; Valdivia MI; Oña MR; Roset M; Mora AM; Hernández M Neurourol Urodyn; 2017 Mar; 36(3):774-779. PubMed ID: 27120009 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of urinary symptoms in patients with post-prostatectomy urinary incontinence treated with the male sling TOMS. Yiou R; Loche CM; Lingombet O; Abbou C; Salomon L; de la Taille A; Audureau E Neurourol Urodyn; 2015 Jan; 34(1):12-7. PubMed ID: 24142704 [TBL] [Abstract][Full Text] [Related]
54. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes. Garely AD; Lucente V; Vapnek J; Smith N Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526 [TBL] [Abstract][Full Text] [Related]
55. Use of free uroflowmetry vs pressure-flow studies in the diagnosis of overactive bladder syndrome in females. Nowakowski Ł; Futyma K; Ziętek A; Bogusiewicz M; Gałczyński K; Rechberger T Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():137-140. PubMed ID: 27852010 [TBL] [Abstract][Full Text] [Related]
56. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Peyronnet B; Mironska E; Chapple C; Cardozo L; Oelke M; Dmochowski R; Amarenco G; Gamé X; Kirby R; Van Der Aa F; Cornu JN Eur Urol; 2019 Jun; 75(6):988-1000. PubMed ID: 30922690 [TBL] [Abstract][Full Text] [Related]
58. Predictors of variability in urinary incontinence and overactive bladder symptoms. Stewart WF; Minassian VA; Hirsch AG; Kolodner K; Fitzgerald M; Burgio K; Cundiff GW; Blaivas J; Newman D; Lerch VR; Dilley A Neurourol Urodyn; 2010 Mar; 29(3):328-35. PubMed ID: 19693956 [TBL] [Abstract][Full Text] [Related]
59. Characterization of symptom bother and health-related quality of life in Japanese female patients with overactive bladder. Gotoh M; Kobayashi T; Sogabe K Neurourol Urodyn; 2015 Nov; 34(8):730-5. PubMed ID: 25212503 [TBL] [Abstract][Full Text] [Related]
60. Bothersome lower urinary tract symptoms 1 year after first delivery: prevalence and the effect of childbirth. van Brummen HJ; Bruinse HW; van de Pol G; Heintz AP; van der Vaart CH BJU Int; 2006 Jul; 98(1):89-95. PubMed ID: 16831150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]